A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol.
<h4>Background</h4>Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adher...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec5bc0d4292f47e8a3a30af7c61bd407 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ec5bc0d4292f47e8a3a30af7c61bd407 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ec5bc0d4292f47e8a3a30af7c61bd4072021-12-02T20:10:07ZA mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol.1932-620310.1371/journal.pone.0253526https://doaj.org/article/ec5bc0d4292f47e8a3a30af7c61bd4072021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253526https://doaj.org/toc/1932-6203<h4>Background</h4>Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined.<h4>Methods</h4>Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients' subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications.<h4>Discussion</h4>Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population.Sandra MichielsSandra Tricas-SaurasMarie DauvrinDominique BronFati Kirakoya-SamadoulougouPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0253526 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sandra Michiels Sandra Tricas-Sauras Marie Dauvrin Dominique Bron Fati Kirakoya-Samadoulougou A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
description |
<h4>Background</h4>Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined.<h4>Methods</h4>Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients' subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications.<h4>Discussion</h4>Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population. |
format |
article |
author |
Sandra Michiels Sandra Tricas-Sauras Marie Dauvrin Dominique Bron Fati Kirakoya-Samadoulougou |
author_facet |
Sandra Michiels Sandra Tricas-Sauras Marie Dauvrin Dominique Bron Fati Kirakoya-Samadoulougou |
author_sort |
Sandra Michiels |
title |
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
title_short |
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
title_full |
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
title_fullStr |
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
title_full_unstemmed |
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol. |
title_sort |
mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: the madesio protocol. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/ec5bc0d4292f47e8a3a30af7c61bd407 |
work_keys_str_mv |
AT sandramichiels amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT sandratricassauras amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT mariedauvrin amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT dominiquebron amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT fatikirakoyasamadoulougou amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT sandramichiels mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT sandratricassauras mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT mariedauvrin mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT dominiquebron mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT fatikirakoyasamadoulougou mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol |
_version_ |
1718375034907525120 |